The osteogenic differentiation of BMMSCs (CD45−, CD146+, CD105+, CD90+, CD44+) from MDS/AML patients was decreased significantly; in contrast, their adipogenic differentiation was increased (Fig. 1A, S1A). This evidence concerns the gene CD44 and acute myeloid leukemia.